• Company
• Pharmaceutical shares capitalization of ₩56 trillion
• by Chon, Seung-Hyun Jan 1, 2023 10:42pm

• Policy
• Australia, excluding drug price reference countries
• by Lee, Tak-Sun Jan 1, 2023 10:40pm

• Policy
• New formulations of narcotics will be as strictly reviewed
• by Lee, Jeong-Hwan Dec 30, 2022 06:33am

• Policy
• Gov allocates KRW1.47 trillion budget for healthcare R&D
• by Kim, Jung-Ju Dec 30, 2022 06:33am

• Company
• Korea develops 2 new drugs and 2 biosimilars in 2022
• by Chon, Seung-Hyun Dec 29, 2022 06:04am

• Company
• EUA for Zochova was not requested
• by Kim, Jin-Gu Dec 29, 2022 06:04am

• Policy
• A rapid change in the population
• by Kang, Shin-Kook Dec 29, 2022 06:03am

• Policy
• Takeda CMV infection treatment Livtencity has been approved
• by Kim, Jung-Ju Dec 29, 2022 06:03am

• Company
• Daewoong and Neurorive will codevelop new antidepressant
• by Lee, Seok-Jun Dec 29, 2022 06:03am

• Company
• LegoChem Bio may receive milestone payments next yr
• by Dec 28, 2022 05:49am